Reprogramming Chronic Care: AI-Driven Digital Therapeutics for a Connected, Personalized and Equitable Health Future
| dc.contributor.author | Soumarshi Das | |
| dc.contributor.author | Ravinder Singh | |
| dc.date.accessioned | 2026-08-12T04:58:22Z | |
| dc.date.available | 2026-08-12T04:58:22Z | |
| dc.date.issued | 2025-10-20 | |
| dc.description.abstract | Background: Non-communicable diseases such as diabetes, cardiovascular disease, and mental disorders contribute to 74% of global annual deaths, creating a major strain on healthcare systems. Conventional episodic care models are inadequate for continuous management, highlighting the need for innovative solutions. Purpose: This review systematically evaluates the role of AI-powered Digital Therapeutics (DTx) in chronic disease management, examining clinical evidence, therapeutic outcomes, regulatory frameworks, and future integration with multidisciplinary healthcare systems, with a focus on low- and middle-income settings such as India. Methods: A comprehensive literature search of clinical trials, meta-analyses, and real-world studies was conducted. Regulatory frameworks like the FDA’s Software as a Medical Device (SaMD) and India’s Ayushman Bharat Digital Mission (ABDM) were analyzed to assess the positioning of Digital Therapeutics (DTx) in healthcare systems. Results: Digital therapeutics (DTx) showed significant advantages in chronic disease management: HbA1c reduction of 0.67% in Type 2 Diabetes patients, improved hypertension control with 84% of patients maintaining sustained blood pressure control over three years, and PHQ-9 score reductions by 7.3 points in depression. The AI-driven DTx platform provided real-time adaptive interventions using digital biomarkers and phenotyping. Despite these outcomes, widespread adoption faces challenges from low digital literacy, regulatory uncertainty, and inadequate reimbursement structures, especially in India. Conclusion: AI-powered Digital Therapeutics (DTx) offer transformative solutions for chronic disease management by enabling personalized, adaptive care. Integrating DTx with Electronic Health Records (EHRs) enhances clinical decision-making and preventive care, but implementation is hampered by regulatory fragmentation and technological gaps. | |
| dc.identifier.issn | 2321-2217 | |
| dc.identifier.issn | 2321-2225 | |
| dc.identifier.other | https://doi.org/10.15415/jptrm.2025.131004 | |
| dc.identifier.uri | https://dspace.chitkara.edu.in/handle/123456789/703 | |
| dc.language.iso | en | |
| dc.publisher | Chitkara University Publications | |
| dc.subject | Digital therapeutics (DTx) | |
| dc.subject | Chronic disease management | |
| dc.subject | Artificial intelligence (AI) in healthcare | |
| dc.subject | Personalized medicine | |
| dc.subject | Digital phenotyping | |
| dc.title | Reprogramming Chronic Care: AI-Driven Digital Therapeutics for a Connected, Personalized and Equitable Health Future | |
| dc.type | Article |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed to upon submission
- Description: